United StatesBevacizumab 1.75 mg/0.07 mL supplied in 0.25 mL intravitreal syringes (0.07 mL total volume), Rx only, refrigerated, distributed by RC Outsourcing LLC, Lowellville, OH, lot numbers 20250708-768A26 (BUD Oct 06, 2025), 20250715-944DF2 (BUD Oct 13, 2025), 20250722-55C603 (BUD Oct 20, 2025) and 20250722-5DC113 (BUD Oct 20, 2025), sold nationwide. It was recalled because of a lack of assurance of sterility.
What's being recalled
Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringe, Intravitreal, 0.07 mL Total Volume, Rx Only, Hospital/Office Use Only, Refrigerate, RC Outsourcing LLC, Lowellville, OH 44436.
Recalling firm: RC Outsourcing, LLC, Lowellville, OH, United States.
How to identify it
Lot # 20250708-768A26, BUD: Oct 06, 2025 20250715-944DF2 BUD: Oct 13, 2025 20250722-55C603 BUD: Oct 20, 2025 20250722-5DC113 BUD: Oct 20, 2025
The hazard
Lack of assurance of sterility.
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
Nationwide in the US
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)